Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival

Oncotarget

Volumn 6, Issue 4, 2015, Pages 2573-2582

  Kong, Jinyu ^a,b,c   Xu, Fangxiu ^a   Qu, Jinli ^a   Wang, Yu ^a   Gao, Ming ^a   Yu, Herbert ^d   Qian, Biyun ^a,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Genetic susceptibility; Non small cell lung cancer; Prognosis; Single nucleotide polymorphism; Vitamin D pathway

Indexed keywords

COLECALCIFEROL 24 HYDROXYLASE; CYTOCHROME P450; CYTOCHROME P450 27B1; RNA; UNCLASSIFIED DRUG; VITAMIN D; CALCIDIOL 1 MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VERY ELDERLY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BIOSYNTHETIC PATHWAYS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; VITAMIN D; VITAMIN D3 24-HYDROXYLASE;

EID: 84922971837     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2951     Document Type: Article

References (43)

1. Spiro SG, Silvestri GA. One hundred years of lung cancer. American journal of respiratory and critical care medicine. 2005; 172(5):523-529.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61(2):69-90.
3. de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiologic clinics of North America. 2012; 50(5):863-876.
4. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005; 366(9499):1784-1793.
5. Sugimura H, Tao H, Suzuki M, Mori H, Tsuboi M, Matsuura S, Goto M, Shinmura K, Ozawa T, Tanioka F, Sato N, Matsushima Y, Kageyama S, Funai K, Chou PH, Matsuda T. Genetic susceptibility to lung cancer. Front Biosci (Schol Ed). 2011; 3:1463-1477.
6. Risch A, Plass C. Lung cancer epigenetics and genetics. International journal of cancer Journal international du cancer. 2008; 123(1):1-7.
7. Kimball S, Fuleihan Gel H, Vieth R. Vitamin D: a growing perspective. Critical reviews in clinical laboratory sciences. 2008; 45(4):339-414.
8. Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006; 15(11):2239-2245.
9. Ali MM, Vaidya V. Vitamin D and cancer. Journal of cancer research and therapeutics. 2007; 3(4):225-230.
10. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T. 1 alpha, 25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis. 2005; 26(2):429-440.
11. Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. The Journal of steroid biochemistry and molecular biology. 2006; 102(1-5):156-162.
12. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Frontiers in bioscience: a journal and virtual library. 2005; 10:2723-2749.
13. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer causes & control: CCC. 2005; 16(2):83-95.
14. Kilkkinen A, Knekt P, Heliovaara M, Rissanen H, Marniemi J, Hakulinen T, Aromaa A. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008; 17(11):3274-3278.
15. Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005; 14(10):2303-2309.
16. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007; 25(5):479-485.
17. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008; 181(10):7090-7099.
18. Mawer EB, Hayes ME, Heys SE, Davies M, White A, Stewart MF, Smith GN. Constitutive synthesis of 1, 25-dihydroxyvitamin D3 by a human small cell lung cancer cell line. The Journal of clinical endocrinology and metabolism. 1994; 79(2):554-560.
19. Yokomura K, Suda T, Sasaki S, Inui N, Chida K, Nakamura H. Increased Expression of the 25-Hydroxyvitamin D3-1a-Hydroxylase Gene in Alveolar Macrophages of Patients with Lung Cancer. The Journal of Clinical Endocrinology & Metabolism. 2003; 88(12):5704-5709.
20. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, O'Donovan MC. Functional analysis of human promoter polymorphisms. Human molecular genetics. 2003; 12(18):2249-2254.
21. Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL. Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 2010; 70(13):1448-1460.
22. Gronostajski RM, Adhya S, Nagata K, Guggenheimer RA, Hurwitz J. Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Molecular and cellular biology. 1985; 5(5):964-971.
23. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene. 2000; 249(1-2):31-45.
24. Furlong EE, Rein T, Martin F. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Molecular and cellular biology. 1996; 16(10):5933-5945.
25. Nayak BK, Das BR. Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours. Molecular biology reports. 1999; 26(4):223-230.
26. Singh J, Murata K, Itahana Y, Desprez PY. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 2002; 21(12):1812-1822.
27. Ramnath N, Kim S, Christensen PJ. Vitamin D and lung cancer. Expert review of respiratory medicine. 2011; 5(3):305-309.
28. Parise RA, Egorin MJ, Kanterewicz B, Taimi M, Petkovich M, Lew AM, Chuang SS, Nichols M, El-Hefnawy T, Hershberger PA. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. International journal of cancer Journal international du cancer. 2006; 119(8):1819-1828.
29. Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer chemotherapy and pharmacology. 2006; 57(2):234-240.
30. Chen G, Kim SH, King AN, Zhao L, Simpson RU, Christensen PJ, Wang Z, Thomas DG, Giordano TJ, Lin L, Brenner DE, Beer DG, Ramnath N. CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011; 17(4):817-826.
31. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature genetics. 1999; 22(3):231-238.
32. Dong J, Hu Z, Wu C, Guo H, Zhou B, Lv J, Lu D, Chen K, Shi Y, Chu M, Wang C, Zhang R, Dai J, Jiang Y, Cao S, Qin Z, et al. Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nature genetics. 2012; 44(8):895-899.
33. Kisker O, Onizuka S, Becker CM, Fannon M, Flynn E, D'Amato R, Zetter B, Folkman J, Ray R, Swamy N, Pirie-Shepherd S. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia. 2003; 5(1):32-40.
34. Yamamoto N, Suyama H, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). International journal of cancer Journal international du cancer. 2008; 122(2):461-467.
35. Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011; 20(8):1708-1717.
36. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, Thun MJ, Calle EE. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast cancer research: BCR. 2007; 9(1):R9.
37. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008; 17(6):1339-1343.
38. Karami S, Andreotti G, Koutros S, Barry KH, Moore LE, Han S, Hoppin JA, Sandler DP, Lubin JH, Burdette LA, Yuenger J, Yeager M, Freeman LE, Blair A, Alavanja MC. Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013; 22(9):1557-1566.
39. Zhou L, Zhang X, Chen X, Liu L, Lu C, Tang X, Shi J, Li M, Zhou M, Zhang Z, Xiao L, Yang M. GC Glu416Asp and Thr420Lys polymorphisms contribute to gastrointestinal cancer susceptibility in a Chinese population. International journal of clinical and experimental medicine. 2012; 5(1):72-79.
40. Flohil SC, de Vries E, van Meurs JB, Fang Y, Stricker BH, Uitterlinden AG, Nijsten T. Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas. Experimental dermatology. 2010; 19(12):1103-1105.
41. Li LH, Yin XY, Wu XH, Zhang L, Pan SY, Zheng ZJ, Wang JG. Serum 25(OH)D and vitamin D status in relation to VDR, GC and CYP2R1 variants in Chinese. Endocrine journal. 2014; 61(2):133-141.
42. Santos BR, Mascarenhas LP, Boguszewski MC, Spritzer PM. Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study. Hormone research in paediatrics. 2013; 79:162-168.
43. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM. Genetic and environmental determinants of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels in Hispanic and African Americans. The Journal of clinical endocrinology and metabolism. 2008; 93(9):3381-3388.